PubMed

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies.

Pratley RE, McCall T, Fleck PR, Wilson CA, Mekki Q.

J Am Geriatr Soc. 2009 Sep 30. [Epub ahead of print]PMID: 19793357 [PubMed - as supplied by publisher]Related articles

Plasma Amyloid-beta Peptide Levels Correlate with Adipocyte Amyloid Precursor Protein Gene Expression in Obese Individuals.

Lee YH, Martin JM, Maple RL, Tharp WG, Pratley RE.

Neuroendocrinology. 2009 Aug 12. [Epub ahead of print]PMID: 19672057 [PubMed - as supplied by publisher]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 009 Group.

Curr Med Res Opin. 2009 Oct;25(10):2361-71.PMID: 19650752 [PubMed - in process]Related articles

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study.

Blonde L, Dagogo-Jack S, Banerji MA, Pratley RE, Marcellari A, Braceras R, Purkayastha D, Baron M.

Diabetes Obes Metab. 2009 Oct;11(10):978-86. Epub 2009 Jul 13.PMID: 19614942 [PubMed - in process]Related articles

Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.

Gilbert MP, Pratley RE.

Eur J Intern Med. 2009 Jul;20 Suppl 2:S309-18. Epub 2009 Jun 21. Review.PMID: 19580950 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.

Gilbert MP, Pratley RE.

Am J Med. 2009 Jun;122(6 Suppl):S11-24. Review.PMID: 19464424 [PubMed - indexed for MEDLINE]Related articles

Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes.

Pratley RE.

J Am Acad Nurse Pract. 2008 Nov;20 Suppl 1:7-11. Review. No abstract available. PMID: 19402254 [PubMed - indexed for MEDLINE]Related articles

Expanding treatment options for type 2 diabetes: the old and the new.

Pratley RE.

Diabetes Educ. 2009 Jan-Feb;35 Suppl 1:4S-11S. Erratum in: Diabetes Educ. 2009 May-Jun;35(3):504. PMID: 19218561 [PubMed - indexed for MEDLINE]Related articles

Weight loss and diets: which diet works best?

Carlson A, Pratley RE.

Curr Diab Rep. 2009 Feb;9(1):35-6. No abstract available. PMID: 19192422 [PubMed]Related articles

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.

Pratley RE.

Expert Opin Pharmacother. 2009 Feb;10(3):503-12. Review.PMID: 19191685 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.

Diabetes Obes Metab. 2009 Feb;11(2):167-76.PMID: 19125778 [PubMed - indexed for MEDLINE]Related articles

Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes.

D'Alessio DA, Denney AM, Hermiller LM, Prigeon RL, Martin JM, Tharp WG, Saylan ML, He Y, Dunning BE, Foley JE, Pratley RE.

J Clin Endocrinol Metab. 2009 Jan;94(1):81-8. Epub 2008 Oct 28.PMID: 18957505 [PubMed - indexed for MEDLINE]Related articles

Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors.

Pratley RE, Gilbert M.

Rev Diabet Stud. 2008 Summer;5(2):73-94. Epub 2008 Aug 10.PMID: 18795210 [PubMed - in process]Related articlesFree article

Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes.

Pratley RE.

Medscape J Med. 2008 Jul 28;10(7):171. Review.PMID: 18769687 [PubMed - indexed for MEDLINE]Related articlesFree article

The cannabinoid CB1 receptor is expressed in pancreatic delta-cells.

Tharp WG, Lee YH, Maple RL, Pratley RE.

Biochem Biophys Res Commun. 2008 Aug 8;372(4):595-600. Epub 2008 May 27.PMID: 18505678 [PubMed - indexed for MEDLINE]Related articles

Amyloid precursor protein expression is upregulated in adipocytes in obesity.

Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE.

Obesity (Silver Spring). 2008 Jul;16(7):1493-500. Epub 2008 May 15.PMID: 18483477 [PubMed - indexed for MEDLINE]Related articles

Clinical measures of islet function: usefulness to characterize defects in diabetes.

Ahrén B, Pratley RE, Soubt M, Dunning BE, Foley JE.

Curr Diabetes Rev. 2008 May;4(2):129-45. Review.PMID: 18473760 [PubMed - indexed for MEDLINE]Related articles

Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.

Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR.

Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1035-45. Epub 2008 Apr 15.PMID: 18413671 [PubMed - indexed for MEDLINE]Related articlesFree article

LAP-BAND or medical therapy for metabolic syndrome?

Gilbert M, Pratley RE.

Curr Diab Rep. 2008 Feb;8(1):5-6. No abstract available. PMID: 18366991 [PubMed]Related articles

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.

Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S.

Diabetes Obes Metab. 2008 Sep;10(10):931-8. Epub 2007 Dec 17.PMID: 18093207 [PubMed - indexed for MEDLINE]Related articles

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.

Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S.

Diabetes Care. 2007 Dec;30(12):3017-22. Epub 2007 Sep 18.PMID: 17878242 [PubMed - indexed for MEDLINE]Related articlesFree article

On rendering continuous glucose monitoring ready for prime time in the cardiac care unit.

Rowen M, Schneider DJ, Pratley RE, Sobel BE.

Coron Artery Dis. 2007 Aug;18(5):405-9.PMID: 17627191 [PubMed - indexed for MEDLINE]Related articles

Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.

Lee YH, Pratley RE.

J Cardiopulm Rehabil Prev. 2007 Jan-Feb;27(1):2-10. Review. No abstract available. PMID: 17474638 [PubMed - indexed for MEDLINE]Related articles

Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?

Salsali A, Pratley RE.

Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):450-1. Epub 2007 Apr 24. No abstract available. PMID: 17457306 [PubMed]Related articles

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.

Pratley RE, Salsali A.

Curr Med Res Opin. 2007 Apr;23(4):919-31. Review.PMID: 17407649 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome: why the controversy?

Pratley RE.

Curr Diab Rep. 2007 Feb;7(1):56-9. Review.PMID: 17348123 [PubMed - indexed for MEDLINE]Related articles

The DREAM Trial: using ramipril and rosiglitazone to prevent diabetes.

Shah V, Pratley RE.

Curr Diab Rep. 2007 Feb;7(1):53-5. No abstract available. PMID: 17254518 [PubMed]Related articles

Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.

Pratley RE, Jauffret-Kamel S, Galbreath E, Holmes D.

Horm Metab Res. 2006 Jun;38(6):423-8.PMID: 16823726 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance increases PAI-1 in the heart.

Sobel BE, Schneider DJ, Lee YH, Pratley RE.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):102-7. Epub 2006 May 22.PMID: 16750510 [PubMed - indexed for MEDLINE]Related articles

Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.

Sobel BE, Lee YH, Pratley RE, Schneider DJ.

Life Sci. 2006 Sep 20;79(17):1600-5. Epub 2006 May 19.PMID: 16750223 [PubMed - indexed for MEDLINE]Related articles

The PROactive Study: pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes.

Pratley RE.

Curr Diab Rep. 2006 Feb;6(1):45-6. No abstract available. PMID: 16522280 [PubMed - indexed for MEDLINE]Related articles

Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.

Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E.

Diabetes Care. 2005 May;28(5):1132-8.PMID: 15855578 [PubMed - indexed for MEDLINE]Related articlesFree article

The evolving role of inflammation in obesity and the metabolic syndrome.

Lee YH, Pratley RE.

Curr Diab Rep. 2005 Feb;5(1):70-5. Review.PMID: 15663921 [PubMed - indexed for MEDLINE]Related articles

Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians.

Stefan N, Stumvoll M, Weyer C, Bogardus C, Tataranni PA, Pratley RE.

Diabet Med. 2004 Oct;21(10):1090-5.PMID: 15384955 [PubMed - indexed for MEDLINE]Related articles

The quality of fat in the diet and its impact on insulin sensitivity.

Pratley RE.

Curr Diab Rep. 2002 Feb;2(1):69-70. No abstract available. PMID: 15279020 [PubMed]Related articles

Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.

Stefan N, Weyer C, Levy-Marchal C, Stumvoll M, Knowler WC, Tataranni PA, Bogardus C, Pratley RE.

Metabolism. 2004 Jul;53(7):904-11.PMID: 15254885 [PubMed - indexed for MEDLINE]Related articles

Taste preferences and body weight changes in an obesity-prone population.

Salbe AD, DelParigi A, Pratley RE, Drewnowski A, Tataranni PA.

Am J Clin Nutr. 2004 Mar;79(3):372-8.PMID: 14985209 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR.

Lee YH, Tokraks S, Pratley RE, Bogardus C, Permana PA.

Diabetologia. 2003 Nov;46(11):1567-75. Epub 2003 Oct 24.PMID: 14576983 [PubMed - indexed for MEDLINE]Related articles

Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes.

Pratley RE.

Curr Diab Rep. 2003 Feb;3(1):63-4. No abstract available. PMID: 12685440 [PubMed]Related articles

Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Pratley RE, Weyer C.

Curr Diab Rep. 2002 Jun;2(3):242-8. Review.PMID: 12643180 [PubMed - indexed for MEDLINE]Related articles

Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians.

Yang X, Pratley RE, Tokraks S, Bogardus C, Permana PA.

Diabetologia. 2002 Nov;45(11):1584-93. Epub 2002 Aug 23.PMID: 12436343 [PubMed - indexed for MEDLINE]Related articles

UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates.

Yang X, Pratley RE, Tokraks S, Tataranni PA, Permana PA.

Mol Genet Metab. 2002 Apr;75(4):369-73.PMID: 12051969 [PubMed - indexed for MEDLINE]Related articles

Sex differences in the human brain's response to hunger and satiation.

Del Parigi A, Chen K, Gautier JF, Salbe AD, Pratley RE, Ravussin E, Reiman EM, Tataranni PA.

Am J Clin Nutr. 2002 Jun;75(6):1017-22. Erratum in: Am J Clin Nutr 2002 Aug;76(2):492. PMID: 12036808 [PubMed - indexed for MEDLINE]Related articlesFree article

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

Diabetes. 2002 Jun;51(6):1884-8.PMID: 12031977 [PubMed - indexed for MEDLINE]Related articlesFree article

Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians.

Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA.

Atherosclerosis. 2002 Mar;161(1):233-42.PMID: 11882337 [PubMed - indexed for MEDLINE]Related articles

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.

Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA.

Diabetes. 2002 Feb;51(2):455-61.PMID: 11812755 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss.

Evidente VG, Caviness JN, Adler CH, Gwinn-Hardy KA, Pratley RE.

Mov Disord. 2001 Sep;16(5):924-7.PMID: 11746624 [PubMed - indexed for MEDLINE]Related articles

Effect of satiation on brain activity in obese and lean women.

Gautier JF, Del Parigi A, Chen K, Salbe AD, Bandy D, Pratley RE, Ravussin E, Reiman EM, Tataranni PA.

Obes Res. 2001 Nov;9(11):676-84.PMID: 11707534 [PubMed - indexed for MEDLINE]Related articles

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.

Pratley RE, Weyer C.

Diabetologia. 2001 Aug;44(8):929-45. Review.PMID: 11484070 [PubMed - indexed for MEDLINE]Related articles